Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Cell Discovery|December 5, 2019
Global alteration of T-lymphocyte metabolism by PD-L1 checkpoint involves a block of de novo nucleoside phosphate synthesisNicolaos Jay Palaskas, Jacob David Garcia, Roksana Shirazi, et al.
Oncotarget|March 24, 2016
Repurposing metformin for cancer treatment: current clinical studiesYoung Kwang Chae, Ayush Arya, Mary-Kate Malecek, et al.
Cancer Medicine|April 30, 2024
Enhanced CTLA-4 blockade anti-tumor immunity with APG-157 combination in a murine head and neck cancerDaniel Sanghoon Shin, Saroj Basak, Mysore S Veena, et al.
Cancer Immunology Research|January 21, 2016
PD-1 Blockade Expands Intratumoral Memory T CellsAntoni Ribas, Daniel Sanghoon Shin, Jesse Zaretsky, et al.
JCO Oncology Practice|June 18, 2026
Maintenance Pemetrexed/Pembrolizumab Versus Pembrolizumab in Non-Small Cell Lung Cancer: A Propensity Score-Weighted AnalysisGarth W Strohbehn, Molly C Tokaz, Daniel Sanghoon Shin, et al.
The Journal of Biological Chemistry|October 8, 2020
Dysregulation of hsa-miR-34a and hsa-miR-449a leads to overexpression of PACS-1 and loss of DNA damage response (DDR) in cervical cancerMysore S Veena, Santanu Raychaudhuri, Saroj K Basak, et al.
Cell Reports|May 13, 2017
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 ExpressionAngel Garcia-Diaz, Daniel Sanghoon Shin, Blanca Homet Moreno, et al.
Nature Communications|February 9, 2024
CAR-T cell therapy targeting surface expression of TYRP1 to treat cutaneous and rare melanoma subtypesSameeha Jilani, Justin D Saco, Edurne Mugarza, et al.
Cancer Research Communications|February 29, 2024
Gigaxonin Suppresses Epithelial-to-Mesenchymal Transition of Human Cancer Through Downregulation of SnailMysore S Veena, Jungmo J Gahng, Mustafa Alani, et al.
Pageof 4